SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that Kenneth F. Buechler, Ph.D., has agreed to join its Board of Directors, effective immediately. Dr. Buechler joins the Board after completing almost 20 years of outstanding service to Biosite Incorporated where he most recently served as its president and chief scientific officer prior to the acquisition of Biosite.
